EDGAR Filing Documents for 0001193125-14-332978

Form 8-K - Current report:

SEC Accession No. 0001193125-14-332978

Filing Date

2014-09-05

Accepted

2014-09-05 08:44:55

Documents

Period of Report

2014-09-05

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d782956d8k.htm	8-K	18467
2	EX-99.1	d782956dex991.htm	EX-99.1	136831
3	EX-99.2	d782956dex992.htm	EX-99.2	5078
4	GRAPHIC	g782956ex99_1s10gbgd.jpg	GRAPHIC	31072
5	GRAPHIC	g782956ex99_1s11gbgd.jpg	GRAPHIC	42090
6	GRAPHIC	g782956ex99_1s12gbgd.jpg	GRAPHIC	35401
7	GRAPHIC	g782956ex99_1s13gbgd.jpg	GRAPHIC	23389
8	GRAPHIC	g782956ex99_1s14gbgd.jpg	GRAPHIC	36786
9	GRAPHIC	g782956ex99_1s15gbgd.jpg	GRAPHIC	32907
10	GRAPHIC	g782956ex99_1s16gbgd.jpg	GRAPHIC	53493
11	GRAPHIC	g782956ex99_1s17gbgd.jpg	GRAPHIC	32673
12	GRAPHIC	g782956ex99_1s18gbgd.jpg	GRAPHIC	31033
13	GRAPHIC	g782956ex99_1s19gbgd.jpg	GRAPHIC	35298
14	GRAPHIC	g782956ex99_1s1gbgd.jpg	GRAPHIC	18766
15	GRAPHIC	g782956ex99_1s20gbgd.jpg	GRAPHIC	30469
16	GRAPHIC	g782956ex99_1s21gbgd.jpg	GRAPHIC	44769
17	GRAPHIC	g782956ex99_1s22gbgd.jpg	GRAPHIC	20340
18	GRAPHIC	g782956ex99_1s23gbgd.jpg	GRAPHIC	49910
19	GRAPHIC	g782956ex99_1s2gbgd.jpg	GRAPHIC	20239
20	GRAPHIC	g782956ex99_1s3gbgd.jpg	GRAPHIC	25418
21	GRAPHIC	g782956ex99_1s4gbgd.jpg	GRAPHIC	49831
22	GRAPHIC	g782956ex99_1s5gbgd.jpg	GRAPHIC	33772
23	GRAPHIC	g782956ex99_1s6gbgd.jpg	GRAPHIC	32550
24	GRAPHIC	g782956ex99_1s7gbgd.jpg	GRAPHIC	36275
25	GRAPHIC	g782956ex99_1s8gbgd.jpg	GRAPHIC	37432
26	GRAPHIC	g782956ex99_1s9gbgd.jpg	GRAPHIC	41077
27	GRAPHIC	g782956img1.jpg	GRAPHIC	7456
	Complete submission text file	0001193125-14-332978.txt		1271167

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803

Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882

Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)